Sleep loss impairment of arousal and cognition: role of the basal forebrain

睡眠不足对觉醒和认知的损害:基底前脑的作用

基本信息

  • 批准号:
    8921583
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-10-01 至 2019-09-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Sleep loss leads to impaired cognitive performance and excessive daytime sleepiness. These symptoms of sleep loss are now recognized as major contributors to accident rates and decreased workplace productivity. Mice will be used to model two types of human sleep loss that produce daytime sleepiness and cognitive impairments: 1) Total sleep deprivation, which can occur due to vocational demands such as shift work or emergency work, and, 2) Sleep fragmentation, a pattern of sleep disturbance seen in many clinical disorders including sleep apnea. Sleep fragmentation disrupts the continuity of sleep and interferes with the restorative effects of sleep. Despite the fact that total sleep time is not greatly reduced by sleep fragmentation, we hypothesize that the physiological and behavioral consequences of sleep fragmentation will be similar to those of total sleep deprivation. The overall goal of this proposa is to understand the role of basal forebrain (BF) neurons in sleep loss induced deficits in wakefulness and vigilance. To accomplish this goal, mice will be used to test the hypothesis that BF GABAergic parvalbumin (PV) and cholinergic - positive neurons enhance wakefulness/alertness, attention, and cortical activation. Both BF PV and cholinergic neurons are hypothesized to be arousal promoting via their cortical projections. Hence, we predict that activation of these arousal promoting BF neurons can reduce sleep-loss induced impairments. Based on preliminary data, we further hypothesize that BF PV neurons will more potently enhance wakefulness, attention, and cortical activation relative to BF cholinergic neurons; PV neurons are also predicted to more effectively reduce the impairments in these measures observed in sleep deprived mice. Abundant evidence indicates that the BF contains cortically projecting and wakefulness promoting neurons that are important for cortical activation and wakefulness (e.g., large non-specific cell body lesions in BF produce a coma-like state). However, only recently have optogenetic methods been available to precisely determine the role of neurotransmitter specific neurons in the brain. Optogenetic inhibition of BF neurons in Aim 1 is predicted to simulate the effects of sleep loss, demonstrating the necessity of BF PV and cholinergic neurons in the sleep loss induced impairments. Aim 2 will determine if: a) excitation of BF neurons is sufficient to enhance wakefulness, attention, and cortical activation in non sleep deprived mice, and, b) excitation of BF neurons will reduce sleep loss induced impairments in wakefulness, attention, and cortical activation. Aim 3 will measure the single unit activity of optogenetically identified BF neurons to confirm that their discharge pattern is consistent with their proposed physiological role in the regulation of natural sleep and wakefulness, and in the mediation of the cortical activity responses to sensory stimuli. The following preliminary data support these hypotheses and predictions: 1. Inhibition of PV neurons reduces measures of wakefulness, attention in the novel object recognition task, and evoked cortical activation; thus, the effects of inhibition of BF PV neurons closely resemble the effects f sleep loss on these measures. 2. Excitation of BF PV neurons produces wakefulness and cortical activation and BF PV unit activity is increased during wakefulness. Compared to BF PV neurons, excitation of cholinergic neurons appears to produce a more modulatory, slower and less powerful behavioral and physiological response. If successful, the experiments proposed will demonstrate mechanistic links between BF unit activity, cortical activation, wakefulness/arousal, and attention. Thus, these findings will guide the development of therapeutic interventions targeting the subcortical arousal promoting neurons to treat the consequences of sleep disorders which are prevalent in the Veteran population.
 描述(由申请人提供): 睡眠不足会导致认知能力受损和白天过度嗜睡。这些睡眠不足的症状现在被认为是事故率和工作效率下降的主要原因。小鼠将用于模拟两种类型的人类睡眠丧失,其产生白天嗜睡和认知障碍:1)完全睡眠剥夺,其可能由于职业需求如轮班工作或紧急工作而发生,以及2)睡眠片段化,在许多临床疾病(包括睡眠呼吸暂停)中观察到的睡眠障碍模式。睡眠碎片会破坏睡眠的连续性,干扰睡眠的恢复作用。尽管总的睡眠时间并没有因为睡眠片段化而大大减少,但我们假设睡眠片段化的生理和行为后果与完全睡眠剥夺的后果相似。这个提议的总体目标是了解基底前脑(BF)神经元在睡眠丧失引起的觉醒和警觉缺陷中的作用。为了实现这一目标,将使用小鼠来测试BF GABA能小清蛋白(PV)和胆碱能阳性神经元增强觉醒/警觉性、注意力和皮质激活的假设。BF PV和胆碱能神经元都被假设为通过它们的皮质投射来促进唤醒。因此,我们预测,这些唤醒促进BF神经元的激活可以减少睡眠损失引起的损害。基于初步的数据,我们进一步假设,BF PV神经元将更有力地增强觉醒,注意力和皮质激活相对于BF胆碱能神经元; PV神经元也预测更有效地减少在睡眠剥夺小鼠中观察到的这些措施的损害。大量证据表明,BF含有皮质投射和觉醒促进神经元,这些神经元对皮质激活和觉醒很重要(例如,BF中大的非特异性细胞体损伤产生昏迷样状态)。然而,直到最近才有光遗传学方法可用于精确确定神经递质特异性神经元在大脑中的作用。目的1中BF神经元的光发生抑制被预测为模拟睡眠丧失的影响,证明BF PV和胆碱能神经元在睡眠丧失引起的损害中的必要性。目标2将确定是否:a)BF神经元的激发足以增强非睡眠剥夺小鼠的觉醒、注意力和皮质激活,和,B)BF神经元的激发将减少睡眠丧失诱导的觉醒、注意力和皮质激活的损伤。目的3将测量光遗传学鉴定的BF神经元的单个单位活动,以确认它们的放电模式与它们在自然睡眠和觉醒的调节中以及在对感觉刺激的皮层活动响应的介导中的所提出的生理作用一致。以下初步数据支持这些假设和预测:1. PV神经元的抑制减少了觉醒的措施,注意力在新的物体识别任务,并诱发皮层激活;因此,BF PV神经元的抑制的影响非常类似于睡眠丧失对这些措施的影响。2. BF PV神经元的兴奋产生觉醒和皮质激活,并且BF PV单位活动在觉醒期间增加。与BF PV神经元相比,胆碱能神经元的兴奋似乎产生更大的调节性、更慢和更弱的行为和生理反应。如果成功的话,所提出的实验将证明BF单元活动,皮层激活,觉醒/唤醒和注意力之间的机械联系。因此,这些发现将指导针对皮质下唤醒促进神经元的治疗干预措施的开发,以治疗退伍军人人群中普遍存在的睡眠障碍的后果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT E STRECKER其他文献

ROBERT E STRECKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT E STRECKER', 18)}}的其他基金

BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10373036
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10618193
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Role of the basal forebrain in sleep loss induced attention impairments
基底前脑在睡眠不足引起的注意力障碍中的作用
  • 批准号:
    10620170
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Sleep loss impairment of arousal and cognition: role of the basal forebrain
睡眠不足对觉醒和认知的损害:基底前脑的作用
  • 批准号:
    9206087
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Role of the basal forebrain in sleep loss induced attention impairments
基底前脑在睡眠不足引起的注意力障碍中的作用
  • 批准号:
    10359072
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Adenosine and the Basal Forebrain in the Control of Behavioral State
腺苷和基底前脑控制行为状态
  • 批准号:
    7786264
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Adenosine and the Basal Forebrain in the Control of Behavioral State
腺苷和基底前脑控制行为状态
  • 批准号:
    7687191
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Adenosine and the Basal Forebrain in the Control of Behavioral State
腺苷和基底前脑控制行为状态
  • 批准号:
    8195550
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Adenosine and the Basal Forebrain in the Control of Behavioral State
腺苷和基底前脑控制行为状态
  • 批准号:
    8258633
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
DOPAMINE RELEASE INDUCED BY 4-METHYLAMINOREX
4-METHYLAMINOREX 诱导的多巴胺释放
  • 批准号:
    2119972
  • 财政年份:
    1991
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
  • 批准号:
    81570244
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
  • 批准号:
    81171113
  • 批准年份:
    2011
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
靶向 A2B 腺苷受体用于胰腺癌的免疫预防
  • 批准号:
    10929664
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Exploring the role of adenosine A2A receptors in Schizophrenia using opto-pharmacologically controlled allosteric modulation.
利用光药理学控制的变构调节探索腺苷 A2A 受体在精神分裂症中的作用。
  • 批准号:
    23K14685
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Role of Adenosine Kinase in Mixed Diastolic Heart Failure and Alzheimer Disease
腺苷激酶在混合性舒张性心力衰竭和阿尔茨海默病中的作用
  • 批准号:
    10679989
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Allostery-driven G protein selectivity in the adenosine A1 receptor
腺苷 A1 受体中变构驱动的 G 蛋白选择性
  • 批准号:
    BB/W016974/1
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Investigation of new test methods for adenosine-sensitive atrioventricular block
腺苷敏感型房室传导阻滞新检测方法的探讨
  • 批准号:
    23K07566
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing the role of adenosine pathway in SIV pathogenesis
探讨腺苷途径在 SIV 发病机制中的作用
  • 批准号:
    10760676
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The role of A1 adenosine receptor signaling in the decline of S. pneumoniae killing by neutrophils in vaccinated aged hosts
A1 腺苷受体信号传导在疫苗接种老年宿主中中性粒细胞杀伤肺炎链球菌下降中的作用
  • 批准号:
    10605737
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Adenosine triphosphate as a master variable for biomass in the oceanographic context
三磷酸腺苷作为海洋学背景下生物量的主变量
  • 批准号:
    2319114
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Biology of Microglia: Adenosine A3 Receptor Suppression
小胶质细胞的生物学:腺苷 A3 受体抑制
  • 批准号:
    RGPIN-2019-06289
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Postnatal development of adenosine kinase in the brainstem network that controls breathing
控制呼吸的脑干网络中腺苷激酶的出生后发育
  • 批准号:
    573323-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了